SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 75 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $832,000 | -82.3% | 416,230 | -65.1% | 0.10% | -82.6% |
| Q1 2017 | $4,709,000 | -34.0% | 1,192,130 | -18.1% | 0.60% | -58.2% |
| Q4 2016 | $7,135,000 | -39.8% | 1,456,056 | -4.9% | 1.44% | -30.7% |
| Q3 2016 | $11,852,000 | +27.9% | 1,531,273 | -7.5% | 2.08% | +1.0% |
| Q2 2016 | $9,270,000 | +50.4% | 1,655,274 | +44.5% | 2.06% | -4.2% |
| Q1 2016 | $6,164,000 | -38.3% | 1,145,779 | -0.1% | 2.15% | -37.5% |
| Q4 2015 | $9,987,000 | -44.7% | 1,146,579 | -46.7% | 3.44% | -26.7% |
| Q3 2015 | $18,051,000 | -53.1% | 2,151,437 | -1.6% | 4.69% | -55.8% |
| Q2 2015 | $38,526,000 | +50.5% | 2,186,520 | -1.2% | 10.61% | +8.0% |
| Q1 2015 | $25,594,000 | +179.3% | 2,214,043 | +143.3% | 9.82% | +58.2% |
| Q4 2014 | $9,165,000 | – | 910,100 | – | 6.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,711,063 | $14,355,000 | 5.36% |
| Avoro Capital Advisors LLC | 2,151,437 | $18,051,000 | 4.69% |
| Cormorant Asset Management, LP | 2,095,334 | $17,580,000 | 2.81% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $2,517,000 | 1.46% |
| AlpInvest Partners B.V. | 86,540 | $726,000 | 1.43% |
| Healthcare Value Capital, LLC | 50,000 | $420,000 | 0.60% |
| Aisling Capital LLC | 353,855 | $2,969,000 | 0.52% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $168,000 | 0.26% |
| HAMILTON LANE ADVISORS LLC | 51,582 | $433,000 | 0.21% |
| Spark Investment Management LLC | 106,400 | $891,000 | 0.12% |